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doi: 10.1016/
j.xkme.2021.04.004In a groundbreaking meeting, leading global kidney disease organizations came together in the fall of
2020 as an International Home Dialysis Roundtable (IHDR) to address strategies to increase access to
and uptake of home dialysis, both peritoneal dialysis and home hemodialysis. This challenge has become
urgent in the wake of the coronavirus disease 2019 (COVID-19) pandemic, during which patients with
advanced kidney disease, who are more susceptible to viral infections and severe complications, must be
able to safely physically distance at home. To boost access to home dialysis on a global scale, IHDR
members committed to collaborate, through the COVID-19 public health emergency and beyond, to
promote uptake of home dialysis on a broad scale. Their commitments included increasing the reach and
influence of key stakeholders with policy makers, building a cooperative of advocates and champions for
home dialysis, working together to increase patient engagement and empowerment, and sharing intelli-
gence about policy, education, and other programs so that such efforts can be operationalized globally. In
the spirit of international cooperation, IHDR members agreed to document, amplify, and replicate
established efforts shown to improve access to home dialysis and support new policies that facilitate
access through procedures, innovation, and reimbursement.© 2021 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).INTRODUCTION
Current Status of Home Dialysis Globally
Globally, 1 in 10 people have had chronic kidney disease
diagnosed and 10.5 million people have advanced kidney
disease, which in most cases requires treatment by either
kidney transplantation or dialysis.1 The global number of
people with advanced kidney disease is increasing at a rate
of 5% to 7% per year, but 2.5 to 7 million do not have
access to these life-saving treatments.2 Patients dependent
on dialysis can either be treated in a clinic with in-center
hemodialysis (HD) or at home through home HD
(HHD) or peritoneal dialysis (PD).3,4 Though dialysis
started as a largely home-based treatment in the 1960s
with HHD, during the past decades it has shifted largely to
in-center dialysis.5
Whereas overall dialysis cost is related to country in-
come (as measured by gross domestic product per capita),
home dialysis is generally less expensive than in-center
dialysis in most high- and middle-income countries.6
Compared with in-center dialysis, home dialysis provides
significant economic, quality-of-life, and clinical advan-
tages.7-12 Clinically, PD has been associated with better
preservation of residual kidney function, fewer hospitali-
zations, and better quality of life, and some data suggest
improved short-term survival compared with in-center
HD.13,14 Patients receiving HHD have been demonstrated
to experience important clinical advantages such as
improved blood pressure, phosphate level control, and
improved sleep compared with in-center patients.15Kidney Med Vol XX | Iss XX | Month 2021At its inception, HHD was used by up to 40% of the
11,000 patients receiving HD in the United States, but the
passage of the Social Security Amendments of 1972, which
included an entitlement for dialysis patients, changed this
paradigm in favor of in-center HD. Although the Medicare
End-Stage Renal Disease program greatly increased the
number of patients able to access dialysis treatment overall,
it created financial incentives for the growth of large
dialysis organizations with economies of scale to establish
in-center facilities. Subsequently care shifted from HHD to
in-center HD due to these unintended disincentives to
home dialysis, and by 1978, <15% of patients dialyzed at
home.16 By 1992, only 1.3% of patients in the United
States were receiving HHD.17 We present a summary of
key milestones in home dialysis care delivery in Fig 1.
However, the advent of novel HHD machines in recent
years, to simplify technology and reduce burden, provide a
new opportunity for a resurgence of HHD.18 Different
therapeutic modalities within HHD, such as low-flow di-
alysates with bags versus conventional monitors and
much-needed efforts to use tunneled central venous cath-
eters if no other vascular access option is possible, are also
important when considering how to increase access to
HHD. Further, with the advent of continuous ambulatory
PD in 1976, PD became another option for home dialysis
because all patients receiving continuous ambulatory PD or
automated PD can be treated at home.19-21 Globally only 9
of 36 countries (Canada, Netherlands, Iceland, Finland,
Denmark, Australia, New Zealand, Mexico, and Hong
Kong) report home dialysis for >20% of prevalent dialysis1
Figure 1. Milestones of home dialysis care delivery. Abbrevia-
tions: CAPD, continuous ambulatory peritoneal dialysis; PD,
peritoneal dialysis.16-22,74
Mendu et alpatients.22 In addition, it is worth noting that differences
in home dialysis uptake across centers have been observed
even in countries for which overall prevalence is low; lo-
calities with a high penetration of home dialysis should be
considered when thinking about how to overcome
country-wide logistical, educational, or financial barriers.
The COVID-19 Pandemic and Home Dialysis
During the past few decades, many kidney health organi-
zations globally have strongly advocated for policy and
practice changes to increase access to and uptake of home
dialysis. These efforts have seen varying levels of success
over the years. The coronavirus disease 2019 (COVID-19)
pandemic has further emphasized the importance of
enabling greater numbers of patients to perform dialysis at
home, given that dialysis patients are at high risk for
developing severe COVID-19 outcomes compared with the
general population and treatment in a dialysis center
challenges efforts to physically distance.23 Home therapies
are recognized as ideal when pandemics break out,
particularly compared with in-center dialysis in which
patients must visit a health care facility at least 3 times per
week.24 Recent Canadian and Italian data demonstrated
that patients receiving in-center dialysis were up to 3 times
more likely to test positive for COVID-19 than patients
receiving home dialysis.25,26 The US Renal Data System
recently reported that the COVID-19 hospitalization rate
for patients undergoing in-center HD was 3 to 4 times that
of patients receiving PD and HHD.27,28 These observations
have prompted a sense of urgency among clinicians and
advocates to find immediate ways to make home dialysis
more available for patients with kidney disease. The
concerted push to help patients access home dialysis dur-
ing the pandemic has shed light on many long-standing
obstacles to home dialysis access that limit uptake.
Given the critical juncture of the COVID-19 pandemic,
vulnerability of the kidney disease population, and long-
standing demonstrated advantages of home dialysis mo-
dalities, leading kidney health organizations throughout the
international community formed an International Home
Dialysis Roundtable (IHDR). The IHDR met during a 2-part
virtual meeting (October and November 2020) to consider
practical steps for increasing access to home dialysis, both
during the still raging pandemic and beyond (meeting
description and invitation provided in Items S1 and S2). The
meetings were divided into sections identifying specific
challenges and designing action solutions for barriers to
home dialysis related to clinicians, patients, and institutions
(including governments) and innovation challenges. The
leaders who participated in this landmark conference
committed to work independently through their organiza-
tions and collaboratively as a group to address barriers that
currently limit home dialysis uptake by focusing on 4 clear
domains of action opportunities: (1) establishment of in-
ternational standards to increase home dialysis; (2)
empowerment of patients, improved shared decision mak-
ing, and reduction of paternalism among health care2
providers; (3) creation of a “culture of support” for home
dialysis among health care providers through education and
training; and (4) creation of internationally shareable best
practices on successful strategies to reduce institutional or
governmental roadblocks to home dialysis (Item S3). Each
participant organization committed to use their own asso-
ciation’s upcoming meetings and online platforms to
advance best practices and foster further discussion of these
goals, to better equip colleagues in disparate regions, find
and develop home dialysis patient and clinician “cham-
pions,” and advocate for pro-home dialysis policy change in
their respective regions.
In this article, we share highlights of the IHDR discus-
sion and outline the action recommendations (Box 1)29-34
agreed on by its members that can serve as a road map for
patients, providers, institutions, and policy makers to
promote home dialysis. We tasked membership and par-
ticipants to engage with their organizations to operation-
alize action items in a resource- and context-specific
manner in different geographies.
INTERNATIONAL STANDARDS AND
COOPERATION
Differences in culture, infrastructure, payment policy, and
economic status exist among countries and regions,
particularly among high-, middle-, and low-incomeKidney Med Vol XX | Iss XX | Month 2021
Box 1. International Home Dialysis Roundtable Policy Action Plan
Action Items
International Standards and Cooperation
Action recommendations were centered around home dialysis education, training, and advocacy standardization across
countries:
1) Development of centralized centers of excellence in home dialysis throughout both developing and developed countries,
2) Standardization of home dialysis education and training for clinicians and health care professionals working with nephrology
and dialysis,
3) Alignment and regional tailoring of advocacy messages through patients and caregivers to motivate policy makers to action in
favor of home dialysis strategies, and
4) Educational and comprehensive education programs about needs of patients and caregivers to reduce the burden of dialysis.
Patient Empowerment and Education
Action recommendations focused on supporting and amplifying existing broad-based patient education efforts and establishing
new avenues for creating awareness:
1) Establishment of kidney disease awareness campaigns through social media and patient-centered events in collaboration with
patient-led organizations;
2) Development and delivery of country-specific home dialysis training modules to clinicians and patients, such as the
International Society for Peritoneal Dialysis and International Society for Hemodialysis’s current educational materials29;
3) Focus on patient stories on a local, national, and regional basis for use in advocacy, provider education and patient awareness
programs;
4) Commitment to work together to create and promote in-person and virtual patient education programs; and
5) Involvement of patients in home dialysis education for patients and clinicians.
Culture of Support for Home Dialysis
Action recommendations focused on developing and sharing advocacy and educational programs for home dialysis clinicians,
across global organizations:
1) Creation of programs across global kidney disease organizations, such as the World Kidney Disease Games, International
Congress of Nephrology, International Society of Nephrology, and organizations focused on related conditions, such as
diabetes, cardiovascular disease and cancer, to advocate across specialties for policy and practice changes related to home
dialysis;
2) Development of clinician training programs for certain key procedures related to dialysis initiation (eg, the South African and
Latin American peritoneal dialysis catheter implantation training programs)30-32;
3) Expansion of an international webinar program aimed at educating clinicians about home dialysis, including one that the In-
ternational Society of Peritoneal Dialysis is currently leading29;
4) Creation of regional clinician mentoring programs, such as Project ECHO in the United States, and the International Society of
Nephrology sister center programs33,34; and
5) Involvement of home dialysis patients in all these actions because their own home dialysis experience is conveyed directly to
other patients, to clinicians, and to policy makers.
Mitigation of Institutional or Governmental Roadblocks
Action recommendations focused on engaging policy leaders in varied countries to close the gap between in-center and home
dialysis reimbursement:
1) Creation of country-wide best practices on how to advocate with policymakers to ensure that vascular access, peritoneal
dialysis catheter placement, and home hemodialysis training programs are prioritized;
2) Incentivized peritoneal dialysis catheter training programs to promote catheter placement;
3) Research efforts that seek to determine how payment policy affects uptake and which barriers to home dialysis are unrelated
and how changes to government policy could affect home dialysis uptake levels; and
4) Involvement and engagement of health care leaders, such as executives of health systems, health policy experts, and health
care organization leaders.
Mendu et alcountries, but the COVID-19 pandemic has highlighted
that many barriers to home dialysis are shared across the
world. Some of these challenges include adequate pro-
vider, clinician, and patient education; access to telehealth
technologies; a lack of home dialysis “champions”; and a
need to further empower and train patients and their
caregivers to take an active role in their care.35-37 Specific
to the COVID-19 pandemic, some kidney disease leaders
expressed concern that physicians were unable to conductKidney Med Vol XX | Iss XX | Month 2021certain procedures required for the initiation of home
dialysis, particularly PD due to regulatory constraints
related to prioritization of catheter procedures.38 As a
consequence, candidates for PD are often forced to either
opt for in-center HD or postpone the start of a necessary
treatment. However, in other countries with no such
regulatory constraints, PD demand and use increased
during this period.39 Whereas some organizations,
including many of those in attendance at the IHDR, work3
Box 2. IHDR Summary of Operationalizing Action Items
We intend to continue our work with the IHDR together as a
group and within each individual organization that signed the
consensus statement to increase home dialysis globally.
Specifically:
Current
Each organization has committed to work on the manu-
script’s action items within their individual structures, pro-
gramming, and advocacy work. We expect to see updates
from these organizations as they make progress toward their
individual goals.
Quarter 2, 2021
We anticipate conducting a survey of IHDR Steering Com-
mittee members and attendees to monitor each group’s
progress toward individual goals. We would also conduct a
call at this time to disseminate updates and ensure that we
are working together as appropriate.
Quarter 4, 2021
We have proposed a meeting of all stakeholders.
Abbreviation: IHDR, International Home Dialysis Roundtable.
Mendu et alcross-nationally and/or cross-regionally to overcome the
challenges mentioned and have seen important successes,
all participants committed to a more strategic and inten-
tional partnership to “move the needle” on home dialysis
rates and agreed that streamlining of disparate initiatives is
needed.
Action Recommendations
Action recommendations were centered around home
dialysis education, training, and advocacy standardization
across countries.
1) Development of centralized centers of excellence in
home dialysis throughout both developing and devel-
oped countries,
2) Standardization of home dialysis education and training
for clinicians and health care professionals working
with nephrology and dialysis,
3) Alignment and regional tailoring of advocacy messages
through patients and caregivers to motivate policy
makers to action in favor of home dialysis strategies,
and
4) Comprehensive education programs about needs of
patients and caregivers to reduce the burden of dialysis.PATIENT EMPOWERMENT AND EDUCATION
It is widely accepted that a lack of adequate patient and
caregiver education is one of many factors that have led
to the low rates of home dialysis uptake globally, with
most patients receiving in-center dialysis.35,40 Besides
physicians and nurses who train and take care of home4
dialysis patients, there is a lack of physician knowledge
related to home dialysis, with very few medical pro-
fessionals having ever seen a patient performing HD or
PD at home.41 Compounding this challenge is the
paternalistic attitude of some hospitals and clinicians,
assuming limited patient understanding about dialysis
and that patients cannot effectively dialyze at home.42
This often results in clinicians steering patients toward
in-center dialysis even if they are potential candidates for
home dialysis.42 Despite evidence that shared decision
making between nephrologists and patients allows for
mutual agreement, a survey study of nephrologists
demonstrated that there are varied approaches to deci-
sion making related to dialysis.43
Another issue is the phenomenon of “crashing into
dialysis,” in which patients are referred late to the
nephrology clinic when they are in imminent need of
dialysis.44 Subsequently, they begin dialysis in-hospital,
without education about dialysis modality options, and
as a result, the opportunity for home dialysis is missed.45
This tendency has been compounded by the COVID-19
pandemic.46 Even if a patient does not “crash” into dial-
ysis, they are often not provided timely predialysis edu-
cation, forestalling proper information and empowerment
for decision making, including modality choice.47 Some
experts have advocated for commencement of predialysis
education based on kidney function level or symptoms, a
widely accepted marker for education initiation is a
glomerular filtration rate < 20 to 25 mL/min/1.73 m2.48
Further, research has shown that adequate predialysis
education can reduce these crash starts and increase the
likelihood of choosing home dialysis or another self-care
modality.48 Self-care modalities include the self-care dial-
ysis unit, another area that would benefit from additional
research and exploration. Self-care and transitional dialysis
units, along with innovative devices, are examples of new
pathways and technologies, which when supported by
appropriate policies and reimbursement could drive resur-
gence in home therapies. IHDR attendees agreed to work
through their organizations and with each other to empower
patients and caregivers to participate actively in choosing the
best modality for their medical needs and for the patients
already dependent on home dialysis to share their stories
during advocacy efforts in favor of home dialysis.
During the IHDR sessions, testimony was provided by
patients about the barriers they faced in receiving home
dialysis. One patient testified: “There should be fully
transparent discussions with patients on ALL options
available. Many patients have never received a full briefing
in advance of their options, which is unacceptable.” Other
patients expressed their support for home dialysis therapy,
stating that it allowed them to maintain a high level of
independence and the ability to work and travel. More-
over, home dialysis has facilitated physical distancing
during the pandemic.49 One HHD patient stated that the
first barrier to be tackled is that “home dialysis is not
available for everyone” and that it would be helpful toKidney Med Vol XX | Iss XX | Month 2021
Mendu et aldevelop a tool for decision making. Another patient
receiving HHD for many years emphasized the need for
autonomy to determine their own treatment at home.
There are countries in which patients are not allowed to
perform HD at home on their own and a trained care partner
(or in some cases a nurse and/or a nephrologist) must be
present during the entire session. Some countries do not
support professional-assisted home dialysis, and this can be a
barrier for those without a care partner if unable to perform
the treatment alone.50 The importance of supporting patients
unable to carry out home dialysis alone, facilitating assisted
home dialysis, either with the help of a relative, a caregiver or
a health care professional, was discussed. Assisted home
dialysis is a meaningful option to home care; dedicated ac-
tions by different groups (such as health care professionals,
patients with kidney disease, caregivers, community, and
payors) should be considered.51 There were concerns raised
about managing, storing, organizing, and disposing of dial-
ysis supplies at home and the need for investment in re-
sources to better support patients and families. All these
patient testimonies reflect a desire for increased clinician ef-
forts to empower patients to take charge of their health de-
cision making and dialysis journey. Increased access to
conversations on self-management of kidney disease, the
rationale behind why certain restrictions or requirements are
put in place, and how to regain what some studies have
termed “lost vitality” are key.52
Patient stakeholders in the IHDR sessions saw a role for
patients as part of the home dialysis education and training
process for both patients and clinicians. Although many
patients noted that they had supported other patients either
through formal peer support programs or informally
through personal connections or within their clinic, they
believed that patient expertise has been grossly underused.
They noted significant room for growth in systematizing
patient partnership at all levels of patient and clinician ed-
ucation and identified many missed opportunities for pa-
tients to partner both with individual providers, dialysis
centers, hospitals, and health care systems. Patients’ unique
perspectives would serve to dispel myths and demonstrate
the benefits and possibilities that a home dialysis lifestyle
can afford, both normalizing and revolutionizing the shared
understanding of the home dialysis patient experience.
Clinicians remarked on the important role of expanded
telemedicine care during the pandemic that has facilitated
remote care of home dialysis patients, and as a result, ef-
forts are needed to mitigate the digital divide affecting
vulnerable patient populations.53,54
Action Recommendations
Action recommendations focused on supporting and
amplifying existing broad-based patient education efforts
and establishing new avenues for creating awareness:
1) Establishment of kidney disease awareness campaigns
through social media and patient-centered events in
collaboration with patient-led organizations;Kidney Med Vol XX | Iss XX | Month 20212) Development and delivery of country-specific home
dialysis training modules to clinicians and patients,
such as the International Society for PD and Interna-
tional Society for HD’s current educational materials29;
3) Focus on patient stories on a local, national, and
regional basis for use in advocacy, provider education
and patient awareness programs;
4) Commitment to work together to create and promote
in-person and virtual patient education programs; and
5) Involvement of patients in home dialysis education for
patients and clinicians.CULTURE OF SUPPORT FOR HOME DIALYSIS
Clinical champions for home dialysis have made critical
differences in the uptake of home therapy in various coun-
tries.55 Nurses in particular are crucial in the administration
of and training for home dialysis and they have a unique
active connection to dialysis patients, with whom they often
have more personalized conversations than phys-
icians.56,57,Although the kidney disease community can
benefit from identifying and promoting additional strong
clinical leaders to educate the public and policymakers about
home dialysis, clinician advocates are not present in every
region or health system.58 IHDR participants discussed the
importance of a wholesale shift in clinical culture to reshuffle
the current philosophy of prioritizing treatment options,
moving from a system that directs most patients to in-center
dialysis to one that more broadly recognizes and supports
home dialysis as a viable first-choice option for patients.
There was a recognition that a coordinated effort must be
made to increase the number of nurse and other clinical
champions for home dialysis, and any cultural shift toward
home dialysis in the nephrology community must include
nurses and the organizations that represent them as well.
In addition, medical, nursing, and pharmacy students
should be thoroughly and objectively educated about
home dialysis therapies. Furthermore, the role of home
dialysis should be an important part of clinical fellowship
curricula in not only nephrology, but also clinicians
managing patients with kidney failure, such as general
practitioners, family physicians, cardiologists, di-
abetologists, oncologists, or vascular surgeons.59 This
should be followed by opportunities to further educate
clinicians throughout their careers, mentoring for clini-
cians, and promoting the application of shared decision
making tools for clinicians and patients to use. Finally, an
important takeaway from the IHDR discussions was that
many organizations were not aware of existing curriculum
and advocacy programs led by other organizations and that
sharing efforts could further help advance a culture shift.
Action Recommendations
Action recommendations focused on developing and
sharing advocacy and educational programs for home
dialysis clinicians, across global organizations:5
Mendu et al1) Creation of programs across global kidney disease or-
ganizations, such as the World Kidney Disease Games,
International Congress of Nephrology, International
Society of Nephrology, ands organizations focused on
related conditions, such as diabetes, cardiovascular
disease, and cancer, to advocate across specialties for
policy and practice changes related to home dialysis;
2) Development of clinician training programs for certain
key procedures related to dialysis initiation (eg, the
South African and Latin American PD catheter implan-
tation training programs)30-32;
3) Expansion of an international webinar program aimed at
educating clinicians about home dialysis, including one
that the International Society of PD is currently leading29;
4) Creation of regional clinician mentoring programs,
such as Project ECHO in the United States, and the
International Society of Nephrology sister center pro-
grams33,34; and
5) Involvement of home dialysis patients in all these ac-
tions because their own home dialysis experience is
conveyed directly to other patients, to clinicians, and to
policy makers.MITIGATION OF INSTITUTIONAL OR
GOVERNMENTAL ROADBLOCKS TO HOME
DIALYSIS
Two major practical barriers to home dialysis use include
vascular or peritoneal catheter placement and payment
disparity (between in-center and home dialysis modal-
ities), which are largely institutional or governmental in
origin.60
Limited access to the procedures to place the catheters
needed to enable PD has long been a challenge in many
countries. The limitations stem from many factors, including
the need for more and better training on the procedure, lack
of diversity in insertion methods, and challenges related to
access to operating rooms that may be in short supply.61-63
The COVID-19 pandemic may have exacerbated these chal-
lenges as the need for immediate catheter placement has
become acute for larger numbers of patients who could
benefit from starting home dialysis to physically distance
safely.39 An additional major barrier to HHD use is the
amount of upfront cost needed for facilities to ensure
necessary staffing and infrastructure to train patients.64,65
Governmental dialysis reimbursement systems are
typically designed to control costs while also ensuring high
quality of treatment and health outcomes. Even so, many
health systems are constructed in a way that directs patients
to in-center dialysis rather than more economically bene-
ficial home dialysis.66,67 An important evolution in pay-
ment reform took place in the United States in 2011 when
equal reimbursement of all dialysis modalities was
implemented and resulted in greater PD uptake (9.4% to
12.6% early PD initiation and 12.1% to 16.1% late PD
use).686
However, there is an unclear relationship between
reimbursement and PD uptake in other countries. For
example, the highest rate of PD use in the European Union
is in Scandinavia (>28%), despite lower reimbursement
than for in-hospital HD.69,70 However, these governments
reimburse real costs and not a flat sum, obviating financial
benefit or loss to the clinical team. In addition, there are
educational “home dialysis first initiatives” led by national
or local kidney health communities.71 Some data suggest
that equity of reimbursement coupled with a PD-first
policy may be effective in promoting greater PD use.71
HHD reimbursement is often intermediate between in-
center HD and PD.72 However, most countries have no
specific regulations for HHD, which can be counterpro-
ductive for the uptake of this strategic option.73 Finally,
further research and engagement of policy makers is
warranted regarding whether incentivizing home dialysis
beyond in-center rates would increase uptake for PD and/
or HHD.
The IHDR discussion focused on that fundamental
changes are needed to the structure of medical payments
and reimbursements that support vascular or peritoneal
access placement and home dialysis modalities. Discus-
sants advocated for parity in reimbursements among the
various dialysis modalities, coupled with a home
dialysis-first approach supported by governments and
their health systems.
Action Recommendations
Action recommendations focused on engaging policy
leaders in varied countries to close the gap between in-
center and home dialysis reimbursement:
1) Creation of country-wide best practices on how to
advocate with policy makers to ensure that vascular
access, PD catheter placement, and HHD training pro-
grams are prioritized;
2) Incentivized PD catheter training programs to promote
catheter placement;
3) Research efforts that seek to determine how payment
policy affects uptake and which barriers to home
dialysis are unrelated and how changes to government
policy could affect home dialysis uptake levels; and
4) Involvement and engagement of health care leaders,
such as executives of health systems, health policy ex-
perts, and health care organization leaders.CONCLUSIONS
The IHDR members agreed that these discussions
should be a springboard for new relationships and
strategic partnerships between patients, experts, orga-
nizations, and advocates from around the world that
can be leveraged to increase access to home dialysis.
Discussants expressed a desire to increase and expand
work across countries and regions to addressKidney Med Vol XX | Iss XX | Month 2021
Mendu et allimitations to home dialysis and to collaborate to
ensure that successful projects can be replicated from
one region to another. A total of 91% of participating
organizations reported that they are working on a
project relevant to increasing home dialysis uptake in
their home country, region, or constituency that they
would be willing to share with the rest of the group.
We have asked members to share updates from their
organizations as they make progress toward these ar-
ticulated goals, and we have proposed a follow-up
meeting in 2021 (Box 2).
There was broad consensus that the action recom-
mendations be shared with government policy regulators
and administrators as policy changes are needed to affect
home dialysis uptake around the world. The IHDR par-
ticipants agreed that the kidney community must use the
enthusiasm from the roundtable discussion and the
momentum created by the pandemic to support and
elevate home dialysis initiatives worldwide. Discussants
made it clear that they are eager to act on the commit-
ments they made in the consensus statement and
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